גאלבוס 50 מ"ג

Country: Израел

Језик: Хебрејски

Извор: Ministry of Health

Активни састојак:

VILDAGLIPTIN 50 MG

Доступно од:

NOVARTIS PHARMA SERVICES AG

АТЦ код:

A10BH02

Фармацеутски облик:

TABLETS

Пут администрације:

PER OS

Произведен од:

NOVARTIS PHARMA STEIN AG, SWITZERLAND

Терапеутска група:

VILDAGLIPTIN

Терапеутске индикације:

Galvus is indicated as an adjunct to diet and exercise in patients with type 2 diabetes mellitus• As monotherapy, if diet and exercise are not sufficient, or• In combination with metformin, or a sulfonylurea if treatment with these oral antidiabetics does not offer sufficient control of blood glucose.As triple oral therapy in combination with• a sulphonylurea and metformin when diet and exercise plus dual therapy with these agents do not provide adequate glycaemic control. Galvus is also indicated for use in combination with insulin (with or without metformin) when diet and exercise plus a stable dose of insulin do not provide adequate glycaemic control.

Датум одобрења:

2013-11-01